NEUROCRINE BIOSCIENCES, INC.
Patent Owner
Stats
- 56 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jan 16, 2018 most recent publication
Details
- 56 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,061 Total Citation Count
- Sep 13, 1994 Earliest Filing
- 73 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9782398 Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereofFeb 06, 15Oct 10, 17[A61K]
9714246 [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating theretoFeb 05, 16Jul 25, 17[C07D]
9422310 Gonadotropin-releasing hormone receptor antagonists and methods relating theretoJan 08, 15Aug 23, 16[C07D, C07C]
8952161 Gonadotropin-releasing hormone receptor antagonists and methods relating theretoJun 05, 13Feb 10, 15[C07D, C07C]
8507536 Gonadotropin-releasing hormone receptor antagonists and methods relating theretoAug 10, 12Aug 13, 13[A61K, C07D, A61P]
8481731 Compounds, pharmaceutical composition and methods relating theretoJun 23, 10Jul 09, 13[A61K, C07D, A61P]
8481738 Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNov 10, 11Jul 09, 13[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0172,255 Condensed N-Heterocyclic Compounds and their Use as CRF Receptor AntagonistsAbandonedOct 31, 07Jul 14, 11[A61K, C07D, A61P]
2009/0023,757 PROCESS FOR PREPARING BICYCLIC COMPOUNDSAbandonedApr 06, 06Jan 22, 09[A61K, C07D, A61P]
7446108 Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonistsExpiredMay 21, 02Nov 04, 08[A01N]
2008/0262,005 Uracil-Type Gonadotropin-Releasing Hormone Receptor Antagonists and Methods Related TheretoAbandonedMay 13, 05Oct 23, 08[A61K, C07D, A61P]
2008/0132,700 HYDRATE OF N-METHYL-N-(3-PHENYL)ACETAMIDE AND PROCESSES AND METHODS RELATED THERETOAbandonedNov 30, 07Jun 05, 08[C07D]
7378552 Monoamine re-uptake inhibitors and methods relating theretoExpiredJun 07, 06May 27, 08[C07C]
7273871 Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonistsExpiredJul 15, 02Sep 25, 07[A61K]
2007/0066,640 Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonistsAbandonedJan 14, 04Mar 22, 07[A61K, C07D]
2007/0021,429 Condensed n-heterocyclic compounds and their use as crf receptor antagonistsAbandonedApr 08, 04Jan 25, 07[A61K, C07D]
2006/0270,659 Pyrazolopyrimidines as CRF receptor antagonistsAbandonedApr 28, 06Nov 30, 06[A61K, C07D]
2006/0252,818 Monoamine re-uptake inhibitors and methods relating theretoAbandonedMay 05, 06Nov 09, 06[A61K, C07D]
2006/0178,403 Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoAbandonedMar 08, 04Aug 10, 06[A61K, C07D]
7067509 Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoExpiredMar 08, 04Jun 27, 06[A61K]
2006/0040,863 Methods for treatment of diabetes using peptide analogues of insulinAbandonedAug 17, 05Feb 23, 06[A61K]
2006/0025,427 Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyr-imidin-7-yl}phenyl)acetamide and compositions and methods related theretoAbandonedJun 27, 05Feb 02, 06[A61K, C07D]
2006/0019,996 Gonadotropin-releasing hormone receptor antagonists and methods relating theretoAbandonedJun 24, 05Jan 26, 06[A61K]
2005/0277,645 Sleep inducing compounds and methods relating theretoAbandonedApr 01, 05Dec 15, 05[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.